Sonoma Pharmaceuticals, Inc. (SNOA): Operating Cash Flow
-$3.93M
Year ended 2026-03-31
-$2.57M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$3.93M | n/m | 2026-06-16, From 2025-04-01 |
| 2025-03-31 | -$88.0K | n/m | 2026-06-16, From 2024-04-01 |
| 2024-03-31 | -$2.40M | n/m | 2025-06-17, From 2023-04-01 |
| 2023-03-31 | -$6.15M | n/m | 2024-06-17, From 2022-04-01 |
| 2022-03-31 | -$4.25M | n/m | 2023-06-21, From 2021-04-01 |
| 2021-03-31 | -$3.38M | n/m | 2022-07-13, From 2020-04-01 |
| 2020-03-31 | -$4.59M | n/m | 2021-07-14, From 2019-04-01 |
| 2019-03-31 | -$11.72M | n/m | 2020-07-10, From 2018-04-01 |
| 2018-03-31 | -$12.44M | n/m | 2019-07-01, From 2017-04-01 |
| 2017-03-31 | -$8.17M | n/m | 2018-06-26, From 2016-04-01 |
| 2016-03-31 | -$8.75M | n/m | 2017-06-28, From 2015-04-01 |
| 2015-03-31 | -$6.69M | n/m | 2016-06-21, From 2014-04-01 |
| 2014-03-31 | -$4.89M | n/m | 2015-06-16, From 2013-04-01 |
| 2013-03-31 | $1.15M | n/m | 2013-06-25, From 2012-04-01 |
| 2012-03-31 | -$4.03M | n/m | 2013-06-25, From 2011-04-01 |
| 2011-03-31 | -$4.43M | n/a | 2012-06-21, From 2010-04-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$3.93M | n/m |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$9.92M | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $1.60M | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$15.26M | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | -$25.94M | n/m |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | -$1.34M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | -$38.21M | n/m |
| Biotricity Inc. (BTCY) | 2026-03-31 | -$719.0K | n/m |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$28.95M | n/m |
Compare SNOA, MDAI, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗